29333R107

(CUSIP Number)
Maximilian Martin
c/o Enhanced Group Inc., 169 Madison Avenue, Suite 15101
New York, NY, 10016
929-357-2672

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
05/07/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 122,230,453 shares of Class A Common Stock outstanding as of May 7, 2026.


SCHEDULE 13D


 
Maximilian Martin
 
Signature:/s/ Emily Tabak
Name/Title:Emily Tabak/Attorney-in-Fact
Date:05/14/2026